Immunotherapy treatments for patients with bladder cancer, head and neck cancer, Hodgkin's lymphoma, and kidney cancer, is useful against malignancy, according to Cancer Progress Report.
The recurrence group had significantly larger tumors than the no-recurrence group.
Open partial nephrectomy had a significantly higher rate of complications.
Paradoxical association could be related to an altered fatty acid pathway.
International committee finds slimmer individuals less likely to develop variety of malignancies.
Robotic surgery may offer some benefits, such as shorter hospital stay and less blood loss.
Mean exposure of 18.80 mg/m3 per year was associated with a significant 11% increased risk among white men.
Some metastatic RCC patients may safely undergo surveillance prior to starting systematic therapy.
Research results provide potential new targets for combination therapy regimens.
Study finds no increased risk of overall complications in patients undergoing robotic partial nephrectomy.
Findings in patients treated for T1a renal cell carcinoma followed with X-ray surveillance.
Patients whose surgical wait time was 3 months or more versus less than 3 months had 10-fold increased odds of having a smaller tumor.
Disseminated cancer at the time of radical nephrectomy is associated with 2-fold increased odds of major perioperative complications.
Most patients discharged home within first 6 hours after surgery; none readmitted.
The drug significantly improves overall and progression-free survival compared with everolimus, researchers report.
The optimal tumor shrinkage threshold for predicting overall and progression-free survival is 10%, researchers concluded.
Four key lifestyle factors include weight, exercise, no smoking, and limiting alcohol.
Findings for self-reported leisure-time physical activity of moderate to vigorous intensity.
The risk is most elevated among individuals aged 44 years or younger.
About 25% of patients who present with metastatic renal cancer will undergo nephrectomy after diagnosis.
Among patients treated with targeted therapy, overall survival was 17.1 months for CN recipients vs 7.7 months for those without CN.
Cytoreductive nephrectomy (CN) use remained stable in the targeted therapy era, but more patients are receiving a combination of CN and systemic therapy.
Study shows no meaningful differences between partial and radical nephrectomy in 5-year rates of local recurrence or cancer-related death.
Findings among patients on chronic antiplatelet therapy for cardioprotection.
Positive surgical margins are associated with a significant 34% increased risk of all-cause mortality.
Elevated neutrophil-to-lymphocyte ratio is associated with larger tumors and greater nuclear grade.
Nephron-sparing surgery decreased the risk of end-stage renal disease by 60% in select patients.
Proteinuria is a predictor for renal functional decline in patients with kidney cancer.
Image-guided testing of tissue from the renal mass may lead to improved treatments, researchers say.
Racial difference found among patients undergoing robotic partial nephrectomy for renal tumors.
Renal and Urology News Articles
- Uric Acid Threshold That Predicts Kidney Stone Formation Identified
- Hypogonadism in Male HD Patients Linked to Poor ESA Response
- Teaching Low Phosphorus Cooking May Improve Hyperphosphatemia
- Elevated CRP Linked With CKD Risk in Rheumatoid Arthritis
- Study Identifies Predictors of HD Initiation After AVF Surgery
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)